Oscar Health
Offers ACA individual-market health plans, ICHRA coverage, and enrollment technology.
Something off on this page? Send us feedback.
Profile
Sells ACA individual-market health plans, including employer-funded ICHRA coverage, and earns most revenue from premiums. An internally built insurance platform supports member navigation and plan operations, while +Oscar, Lucie Health Marketplace, Trove Group, and HealthInsurance.org extend its technology, enrollment, brokerage, and lead-generation capabilities.
Offers Affordable Care Act health plans to individuals, families, and employees using employer-funded ICHRAs across multiple U.S. states, with enrollment concentrated in Florida and Texas. Most revenue comes from insurance premiums; +Oscar sells Campaign Builder engagement technology to providers and payors.
Runs member navigation, utilization management, claims, billing, and benefits on an internally built cloud platform. Lucie Health Marketplace handles plan shopping and enrollment; Trove Group sells individual medical and supplemental coverage; HealthInsurance.org provides education and leads.
Results depend on pricing medical risk, managing claims and risk adjustment, maintaining provider networks, and meeting federal and state rate, capital, and medical-loss-ratio rules. Market participation is renewed annually, and federal advance tax credits fund most premium receipts.
Company facts
Categories
Key statistics
Year to date +103% · Average volume (30d) 5.4M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Goldman Sachs | Reiterate | Neutral | $17 | $30 | |
| Aug 7, 2026 | Robert W. Baird | Target | $27 | |||
| Aug 6, 2026 | Barclays | Reiterate | Overweight | $35 | $39 | |
| Jul 28, 2026 | Piper Sandler | Reiterate | Overweight | $13 | $36 | |
| Jun 15, 2026 | Raymond James | Target | $18 | $30 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026Q2 FY26 | $0.40 | $1.10 | +173.0% | $4.73B | $4.79B | +1.3% | −11.86% |
| May 6, 2026Q1 FY26 | $1.21 | $2.07 | +71.1% | $4.89B | $4.58B | −6.4% | +5.19% |
| Feb 10, 2026Q4 FY25 | −$0.92 | −$1.24 | −34.6% | $3.12B | $2.75B | −12.1% | +5.59% |
| Nov 6, 2025Q3 FY25 | −$0.55 | −$0.53 | +3.6% | $3.05B | $2.99B | −2.2% | +7.00% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $3.05B | $2.86B | $2.99B | $2.81B | $4.65B | $4.88B | |
| Gross profit | $786.6M | $311.0M | $399.7M | $185.2M | $1.42B | $4.88B | |
| Operating income | $297.1M | −$230.5M | −$129.3M | −$333.7M | $704.1M | $383.0M | |
| Net income | $275.3M | −$228.4M | −$137.5M | −$352.6M | $679.0M | $361.8M | |
| Diluted EPS | $0.92 | −$0.84 | −$0.53 | −$1.24 | $2.07 | $1.10 | |
| Gross margin | 25.8% | 10.9% | 13.4% | 6.6% | 30.5% | 100.0% | |
| Operating margin | 9.8% | -8.0% | -4.3% | -11.9% | 15.2% | 7.8% |
Fiscal years (4-quarter sums)FY21 $1.92B · FY22 $4.13B · FY23 $5.86B · FY24 $9.18B · FY25 $11.70B
Balance sheet, Jun 30, 2026Cash & short-term investments $8.56B · Total debt $431.6M · Total assets $11.23B · Shareholders' equity $2.05B
Dividends
No dividends on record.
Ownership
Shares outstanding 259.27M · Float 249.19M · 96.1% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 20.59M | 7.94% | 13F | Aug 7, 2026 |
| T. Rowe Price Investment Management, Inc. | 13.04M | 5.03% | 13F | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | 12.64M | 4.88% | 13F | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 11.03M | 4.25% | 13F | Aug 13, 2026 |
| Vanguard Capital Management LLC | 10.58M | 4.08% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 18, 2026 | Richard Scott Blackley | officer: Chief Financial Officer | −18,750 | $31.74 |
| Jul 1, 2026 | Mario Schlosser | director | −47,500 | $31.24 |
| Jun 30, 2026 | Mark T. Bertolini | director, officer: Chief Executive Officer | −624,244 | $28.48 |
| Jun 29, 2026 | Mark T. Bertolini | director, officer: Chief Executive Officer | −614,752 | $29.26 |
| Jun 26, 2026 | Mark T. Bertolini | director, officer: Chief Executive Officer | −591,168 | $29.28 |
Peers
- Centene
Ambetter is the largest ACA marketplace rival
- Elevance Health
Anthem and Wellpoint overlap in ACA public exchanges
- UnitedHealth Group
UnitedHealthcare pressures exchange pricing and networks
- Molina Healthcare
Medicaid-style cost control overlaps in marketplace plans
- Cigna
Cigna is a smaller but current ACA exchange peer
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Oscar Health | $30.50 | +0.12% | $7.90B | 21.8 | 19.2 | 0.5 | +67.2% |
| Centene | $64.94 | +0.28% | $31.99B | — | 14.3 | 0.2 | +9.9% |
| Elevance Health | $397.30 | +0.72% | $85.54B | 17.5 | 14.5 | 0.4 | +0.1% |
| UnitedHealth Group | $392.50 | −0.12% | $356.86B | 25.3 | 18.4 | 0.8 | +0.4% |
| Molina Healthcare | $200.00 | −0.01% | $10.44B | 1,052.6 | 28.5 | 0.2 | −4.8% |
| Cigna | $279.20 | +0.06% | $73.69B | 11.5 | 8.8 | 0.3 | +6.6% |
| Median | 21.4 | 14.5 | 0.3 | +0.4% |







